Related Experiment Video
Updated: Sep 23, 2026

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
Published on: August 6, 2013
Motor symptoms similar to parkinsonism in heavy smokers
M Burtscher1, R Likar, C Pechlaner
1Health Section of the Austrian Alpine Club, General Hospital of Carinthia, Klagenfurt, Austria.
Abstract:
The major objective in this study was a comparison of the motor performance of young male smokers and non-smokers. We tested the endurance capacity, maximal isometric strength, speed of whole-body movements, flexibility and balancing ability of 74 smokers and 118 non-smokers. Then we measured the balancing ability, the visual reaction time and the speed of limb movements of non-smokers and heavy smokers depending on the time of abstinence from smoking. The balancing ability of heavy smokers deteriorates in comparison with non-smokers after an abstinence period of 11-120 min by 42% (p < 0.05), and after more than 120 min by 51% (p < 0.01). Heavy smokers had a longer reaction time both after 2 hours of abstinence and after smoking. The speed of limb movements is decreased after not smoking for a brief period compared to non-smokers and clearly improved immediately after smoking. This deterioration of motor performance of heavy smokers after a short period of abstinence appears similar to the motor symptoms of Parkinsonism and is "treated" by cigarette smoking.
More Related Videos
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Alterations in Muscle Tone lll

